Promoting safer and wider worldwide use of clozapine

Jose de Leon

doi:10.1016/j.schres.2024.03.003

Promoting safer and wider worldwide use of clozapine

Schizophr Res. 2024 Mar 22:S0920-9964(24)00096-3. doi: 10.1016/j.schres.2024.03.003. Online ahead of print.

Author

Jose de Leon¹

Affiliation

¹ Department of Psychiatry, University of Kentucky, Lexington, KY, USA; Mental Health Research Center, Eastern State Hospital, Lexington, KY, USA; Biomedical Research Centre in Mental Health Net (CIBERSAM), Santiago Apóstol Hospital, University of the Basque Country, Vitoria, Spain. Electronic address: jdeleon@uky.edu.

PMID: 38519290
DOI: 10.1016/j.schres.2024.03.003

Abstract

This issue focuses on the past, the present and the future of clozapine. Of the 43 clozapine articles, nine are historical articles dealing with the past, 29 deal with the present and five with laboratory assays which may influence its future use. These 43 articles include 219 different authors from 56 countries/regions and five continents.

Keywords: Asian; Black or African American; Clozapine/blood; Clozapine/metabolism; Clozapine/therapeutic use; Pneumonia.